首页 >
法规速递
-
Document: Agenda of the CHMP meeting 18-21 May 2026-2026/5/18
2026-05-19查看详情 > -
Document: European Medicines Agency's data protection notice for use of Microsoft Intune for personal and corporate-owned devices-2026/6/30
2026-07-01查看详情 > -
Document: Applications for new human medicines under evaluation: August 2026-2026/8/7
2026-08-09查看详情 > -
国家药监局关于修订倍他司汀制剂说明书的公告（2023年第72号）-2023/6/13
2023-06-14查看详情 > -
关于公开征求ICH《Q5A（R2）：来源于人或动物细胞系生物技术产品的病毒安全性评价》实施建议和中文版意见的通知-2023/12/12
2023-12-21查看详情 > -
Page: Accelerating Clinical Trials in the EU (ACT EU)-2025/1/22
2025-01-23查看详情 > -
Document: New Approach Methodologies EU-IN Horizon Scanning Report-2025/2/24
2025-02-25查看详情 > -
Document: IRIS guide to registration and RPIs-2025/4/1
2025-04-02查看详情 > -
国家药监局关于发布仿制药参比制剂目录（第九十二批）的通告（2025年第20号）-2025/5/13
2025-05-14查看详情 > -
Page: How we work-2025/6/19
2025-06-20查看详情 >
